Search | Webyourself Social Media Platform

Ashwini Bakhade added article Other
2023-12-27 10:12:32 -

Fanconi Anemia Drug Market Poised To Witness High Growth Due To Increasing Disease Prevalence
Fanconi anemia is a rare genetic disorder characterized by bone marrow failure and a predisposition to developing cancer. The current treatments include blood transfusions, antibiotics, antifungals, immunosuppressive drugs, chemotherapy, stem cell or bone marrow transplants. The global fanconi anemia drug market is still in a nascent stage with only one drug currently approved by FDA and EMA...

0 Comments 0 Shares 1170 Views 0 Reviews

Please log in to like, share and comment!
Leena Leena added article Health
2024-02-26 11:54:42 -

The US$ 661.71 Billion Fanconi Anemia Drug Market Is Driven By Increasing Launches Of New Targeted Therapies.
Key TakeawaysKey players operating in the fanconi anemia drug market are Abbott Laboratories, Pfizer Inc., Abbvie Inc., Biocon, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Astrazeneca Plc., Illumina, Inc., Sanofi S.A., Qiagen, Twist Bioscience, Thermo Fisher Scientific Inc., Biointron, Merck & Co., Inc., Sino Biological Inc., GeneWiz (Azenta Life Sciences), Danaher Corporation, and Synbio...

0 Comments 0 Shares 1056 Views 0 Reviews

Please log in to like, share and comment!